Biotech policy, regulations & bioethics form the foundational framework that ensures responsible innovation in biotechnology. As advances in genetic editing, synthetic biology, and personalized medicine accelerate, regulatory agencies and global policymakers face the challenge of balancing innovation with public safety and ethical integrity. This field encompasses the formulation of guidelines governing clinical trials, intellectual property, environmental release, and cross-border biotech trade. Bioethics plays a critical role in addressing concerns surrounding genome editing, data privacy, consent in biobanking, and equity in access to biotech products. Biotech policy, regulations & bioethics ensure transparency, accountability, and societal trust while facilitating global collaboration. A well-regulated landscape not only protects public interests but also accelerates adoption of life-enhancing technologies in healthcare, agriculture, and the environment.
Title : Why do 90% of the drugs fail in development? An analysis of 82+ submissions; and a case study of immunotherapy
Narendra Chirmule, Indian Institute of Technology (IIT), India
Title : Eliminating implant failure in humans with nano chemistry: 45,000 cases and counting
Thomas J Webster, Brown University, United States
Title : Evaluating cell compatibility and subcutaneous host response of silk fibroin–chitosan plug composites as potential resorbable implants
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Steps and strides: Cross-species insights into movement and injury
Babak Faramarzi, Western University of Health Sciences, United States
Title : Ancient wisdom, modern science: Biotech services transforming ayurveda
Prashant Sakharam Bhokardankar, Datta Meghe Ayurvedic Medical College Hospital and Research Centre, India
Title : Scientist’s computational lawyer
Julia Sidorova, Instituto Carlos III de Salud (CIBER-EHD), Spain